Product Information
CHLORHEXIDINE 0.12% RINSE is a generic product labeled by PAI Holdings LLC, priced at $0.0074 per ML under NDC 00121089316. Its NADAC has been published 260 times since Jan 13, 2021.
FDA first approved this application on Dec 15, 1995. Its Orange Book therapeutic-equivalence code is AT.
Strength
1.2 mg/mL
Manufacturer
PAI Holdings LLCNDC
00121089316
Classification
Generic
Dosage Form
RINSE
Route
ORAL
Effective Date
12/17/2025
Active Ingredients
CHLORHEXIDINE GLUCONATEApproval Type
Generic (ANDA)
FDA Application
ANDA074522FDA Approved
12/15/1995
TE Code
AT
On Market Since
12/15/1995
Pharmacological Classes
Price Statistics
The NADAC for CHLORHEXIDINE 0.12% RINSE has been published 260 times since Jan 13, 2021, and over the history we have for it it has risen 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0074 per ML |
|---|---|
| All-time high | $0.0077 (Nov 13, 2024) |
| All-time low | $0.0044 (Jan 17, 2024) |
| 52-week high | $0.0075 |
| 52-week low | $0.0074 |
| Median price | $0.0057 |
| Average price | $0.0062 |
| Largest weekly change | +59.4% (Mar 20, 2024) |
| Weeks tracked | 260 |
| Tracking since | Jan 13, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-1.2%
3Y
+41.6%
5Y
+33.5%
All
+5.1%
Last surveyed Dec 31, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CHLORHEXIDINE GLUCONATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CHLORHEXIDINE GLUCONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORHEXIDINE 0.12% RINSE?
The current National Average Drug Acquisition Cost (NADAC) for CHLORHEXIDINE 0.12% RINSE, manufactured by PAI Holdings LLC, is $0.0074 per ML (NDC 00121089316), effective Dec 31, 2025.
How has the price of CHLORHEXIDINE 0.12% RINSE changed over time?
Over the history we have for it, the NADAC for CHLORHEXIDINE 0.12% RINSE has risen 5.1%. It has been tracked across 260 weekly CMS publications since Jan 13, 2021.
What are the highest and lowest recorded NADAC prices for CHLORHEXIDINE 0.12% RINSE?
Since Jan 13, 2021, the NADAC for CHLORHEXIDINE 0.12% RINSE has ranged from a low of $0.0044 (Jan 17, 2024) to a high of $0.0077 (Nov 13, 2024), with a median of $0.0057 per ML.
Are there cheaper alternatives to CHLORHEXIDINE 0.12% RINSE?
No other NADAC-published product currently shares the active ingredient and strength of CHLORHEXIDINE 0.12% RINSE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLORHEXIDINE 0.12% RINSE?
CHLORHEXIDINE 0.12% RINSE (NDC 00121089316) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.